Pure Biologics S.A. (PURE) aksje
PUR.WA
Stengtzł1.7000-0.0280 (-1.62%)
Laster graf...
PURE
Market Cap
$20,816,018
Åpning1.7380
Høy1.7540
Lav1.6780
Volum81.98k
P/EN/A
Markedsverdi20.82M
52-ukers høy9.2000
52-ukers lav1.3530
Gj.sn. volum524.72k
UtbytteN/A
Beta0.38
EPS-1.5900
Om Pure Biologics S.A. (PURE) aksje
Pure Biologics S.A., a biopharmaceutical company, engages in the research and development of biological drugs and medical devices for therapeutic use. Its therapeutic portfolio in the field of immuno-oncology includes PB003G, which targets the GARP-TGFß1 complex; PB004, an anticancer drug based on an anti-ROR1 antibody; and PB003A, a therapy that targets the aVß8 integrin. The company was founded in 2010 and is based in Wroclaw, Poland.
Selskapsinformasjon
Børs: Warsaw (WSE)
Sektor: Sundhed
Industri: Bioteknologi
Adresse:
Szczytnicka 11
50-382 Wroclaw, Poland
50-382 Wroclaw, Poland
Telefon: + 48 57 000 2829
Nettside: https://purebiologics.com
Analytikernes aksjeanbefalinger
Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.
Laveste kursmål
Gjennomsnittlig kursmål
Median kursmål
Høyeste kursmål